Eric Jon Jacobsen

This inventor holds 46 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Pharmacia & Upjohn Company, Pfizer Corporation, Aclaris Therapeutics, Inc.. Active years: 1996-2025.

USPTO Granted Patents = 46 (Patent Applications = 8)

% Patents Active = 41.3

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 4.1

ph-index = 13

Forward Citations = 632(Granted Patents)

Location History:

Portage, MI (US) (1998)
Plainwell, MI (US) (1996 - 1999)
Kalamazoo, MI (US) (2002 - 2005)
Richland, MI (US) (2002 - 2007)
Chesterfield, MO (US) (2005 - 2023)

Company Filing History:

17 out of 523

Pharmacia & Upjohn Company

Aclaris Therapeutics, Inc.

patents

4. 3 out of 12

Confluence Life Sciences, Inc.

Adaris Therapeutics, Inc.

patent

7. 1 out of 834,411

Other

patents

Years Active: 1996-2025

Loading Chart...

Areas of Expertise:

Pyrrolopyrimidine

ITK Inhibitors

JAK Inhibitors

Azabicyclic Compounds

Heterocyclic Compounds

Inflammation Treatment

Cancer Treatment

Substituted Pyrrolopyridines

Bicyclic Compounds

Tetracyclic Compounds

Arylpyridinone

Hexahydroazepino

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297203 - Pyrrolopyrimidine ITK inhibitors (2025-05-13),

2. 12281111 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same (2025-04-21),

3. 11820775 - Pyrrolopyrimidine ITK inhibitors (2023-11-21),

4. 11739086 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same (2023-08-29),

5. 11420966 - Substituted pyrrolopyridines as JAK inhibitors (2022-08-23),

6. 11021482 - Pyrrolopyrimidine ITK inhibitors (2021-06-01),

7. 10981906 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same (2021-04-20),

8. 10800775 - Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same (2020-10-13),

9. 10316038 - Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer (2019-06-11),

10. 10150783 - Heterocyclic ITK inhibitors for treating inflammation and cancer (2018-12-11),

11. 9695200 - Heterocyclic ITK inhibitors for treating inflammation and cancer (2017-07-04),

12. 9499551 - Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseases (2016-11-22),

13. 9145393 - Arylpyridinone ITK inhibitors for treating inflammation and cancer (2015-09-29),

14. 8633206 - Pyrrolo[2,3-D]pyrimidine compounds (2014-01-21),

15. 8372854 - Pyrrolo[2,3-D]pyrimidine compounds (2013-02-12),

Title: The Innovative Mind of Eric Jon Jacobsen

Introduction: Eric Jon Jacobsen, a talented inventor hailing from Richland, MI, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Eric Jon Jacobsen holds several patents in various fields, including renewable energy, sustainable agriculture, and advanced robotics.

Career Highlights: With a career spanning over two decades, Eric Jon Jacobsen has worked with top research institutions and leading companies to bring his ideas to life. His dedication to pushing the boundaries of technology has led to the development of cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Eric Jon Jacobsen has collaborated with renowned inventors, patent attorneys, and industry experts to enhance his inventions and bring them to the market successfully. His ability to work in multidisciplinary teams has been instrumental in his success.

Conclusion: Eric Jon Jacobsen's passion for innovation and his relentless drive to create a positive impact on society through his inventions make him a true pioneer in the world of technology. His work continues to inspire future generations of inventors to think outside the box and pursue their dreams.